Grant: Idea to Innovation
McMaster University
$125,000.00
Printable and non-biofouling hydrogels for surface modification and biosensing
FY 2018-19
Summary
Preventing protein binding to interfaces is essential in a variety of applications. In biomaterial implants or biomedical devices, protein binding is the first step toward inflammation which can lead to device rejection, secondary infection, and/or patient discomfort. In biosensing applications, protein binding blocks binding sites for the desired target and often induces a false baseline signal that makes biosensor readings less accurate and less sensitive. In bioseparations applications, protein or other molecular binding can block membrane pores and/or change how different species diffuse, reducing the resolution and speed of the separation. In advanced ""lab-on-a-chip"" applications, protein binding can alter the concentration of the target molecule while also requiring high pressures to pump fluids through the device. To address this challenge, we have developed a new hydrogel formulation based on the mixing-induced rapid gelation between hydrazide and aldehyde-functionalized poly(ethylene glycol methacrylate) (POEGMA) precursor polymers. Such polymers can be dip-coated, printed, and/or flow processed to create protein-repellent hydrogels at interfaces of any desired geometry. Compared to other options for fabricating protein-repellent materials, our materials offer the benefits of low viscosity processing, single (or few) step gel formation without the need for external energy, additional chemicals, or non-physiological conditions, and controllable degradation rates. In this Idea to Innovation (Phase 1) proposal, we aim to leverage the highly promising results we have acquired in the context of biomedical applications to generate proof-of-concept data supporting the use of our POEGMA polymers in a lower translational barrier application: protein-repellent coatings on membranes, electrodes, surgical staples,*microfluidic devices, and contact lenses. These applications have attracted direct interest from Canadian commercialization partners, and we envision that the reduction-to-practice of these materials coupled with the planned validation of our technology relative to current coating technologies will attract licensing interest from these (and other) companies to move our hydrogel coating to the market.*
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
520627-2018
Name nom
Hoare, Todd
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
2004
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Polymers and coatings
Research subject fr
Polymères et revêtements
Partie
1
Nb partie
1
Application title
Printable and non-biofouling hydrogels for surface modification and biosensing
Keyword
NSERC
Application summary
Preventing protein binding to interfaces is essential in a variety of applications. In biomaterial implants or biomedical devices, protein binding is the first step toward inflammation which can lead to device rejection, secondary infection, and/or patient discomfort. In biosensing applications, protein binding blocks binding sites for the desired target and often induces a false baseline signal that makes biosensor readings less accurate and less sensitive. In bioseparations applications, protein or other molecular binding can block membrane pores and/or change how different species diffuse, reducing the resolution and speed of the separation. In advanced ""lab-on-a-chip"" applications, protein binding can alter the concentration of the target molecule while also requiring high pressures to pump fluids through the device. To address this challenge, we have developed a new hydrogel formulation based on the mixing-induced rapid gelation between hydrazide and aldehyde-functionalized poly(ethylene glycol methacrylate) (POEGMA) precursor polymers. Such polymers can be dip-coated, printed, and/or flow processed to create protein-repellent hydrogels at interfaces of any desired geometry. Compared to other options for fabricating protein-repellent materials, our materials offer the benefits of low viscosity processing, single (or few) step gel formation without the need for external energy, additional chemicals, or non-physiological conditions, and controllable degradation rates. In this Idea to Innovation (Phase 1) proposal, we aim to leverage the highly promising results we have acquired in the context of biomedical applications to generate proof-of-concept data supporting the use of our POEGMA polymers in a lower translational barrier application: protein-repellent coatings on membranes, electrodes, surgical staples,*microfluidic devices, and contact lenses. These applications have attracted direct interest from Canadian commercialization partners, and we envision that the reduction-to-practice of these materials coupled with the planned validation of our technology relative to current coating technologies will attract licensing interest from these (and other) companies to move our hydrogel coating to the market.*